Search

Search Constraints

You searched for: Author/Creator Mo, H.

Search Results

1. 3055 A prognostic model for platinum-doublet regimens as second-line chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients. (September 2015)

2. A phase 1, randomized, dose‐ranging study of GS‐5816, a once‐daily NS5A inhibitor, in patients with genotype 1–4 hepatitis C virus. Issue 12 (16th July 2015)

3. A phase 3b study of sofosbuvir plus ribavirin in treatment‐naive and treatment‐experienced Korean patients chronically infected with genotype 2 hepatitis C virus. Issue 5 (10th February 2016)

5. All‐oral therapy with nucleotide inhibitors sofosbuvir and GS‐0938 for 14 days in treatment‐naive genotype 1 hepatitis C (NUCLEAR). Issue 10 (31st March 2013)

10. Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy. Issue 11 (18th March 2015)